India to Brazil: Paclitaxel Export Trade Route

The India to Brazil Paclitaxel corridor is one of India's established pharmaceutical export routes, with 77 shipments documented worth a combined $2.5M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 69% of all export value, reflecting the consolidated nature of India's paclitaxel manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $32.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 17.8%, placing it at rank #16 among India's top paclitaxel export destinations globally.

On the import side, key buyers of Indian paclitaxel in Brazil include ACCORD FARMACUTICA LTDA. , ACCORD FARMACUTICA LIMITEDA, ACCORD FARMACUTICA LTDA. and 10 others. ACCORD FARMACUTICA LTDA. is the single largest importer with 17 shipments valued at $646.1K USD.

India's paclitaxel exports to Brazil are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 47 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , KARDI TRADING PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $32.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharma drugs and medicine-paclitaxel injusp 6mg/ml,50ml vial concentrate for i.v.use each ml contains:qty.20958x1x1vial and pharma drugs & medi paclitaxel inj usp 6mg/ml, 16.7ml vial as per invoice, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ACCORD FARMACUTICA LTDA. is the largest importer with 17 shipments worth $646.1K USD — representing 26% of all paclitaxel imports from India on this route. A total of 13 buyers are active on this corridor.